Fig. 2

Receiver operating characteristic (ROC) curves illustrate the predictive abilities of baseline urine interleukin-17 (uIL-17) and the changes in urine interleukin-6 (uIL-6), urine Interleukin-23 (uIL-23), and their combination at 3 months for predicting a 1-year response after induction therapy in patients with LN.